Balance Sheets (USD $)	Apr. 30, 2013	Jul. 31, 2012
Current assets
Cash and cash equivalents	$ 609,901	$ 20,423
Prepaid insurance	29,750
Total current assets	639,651	20,423
Other assets
Patents and patent applications (net of accumulated amortizaton of $3,926 at April 30, 2013 and $2,897 at July 31, 2012)	23,524	24,553
Total assets	663,175	44,976
Liabilities
Accounts payable and accrued liabilities	71,889	55,497
Accrued salaries and wages	272,971	56,300
Due to related party	474,786	136,412
Convertible notes payable, net of debt discounts	186,097	223,693
Derivative liability	183,564	191,792
Total liabilities	1,189,307	663,694
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 145,805,529 shares issued and outstanding at April 30, 2013 and 126,083,416 shares issued and outstanding at July 31, 2012	145,805	126,083
Additional paid-in capital	26,043,316	23,184,094
Accumulated deficit during the development stage	(26,715,253)	(23,928,895)
Total stockholders' equity (deficit)	(526,132)	(618,718)
Total liabilities and stockholders' equity(deficit)	$ 663,175	$ 44,976